Berlin, Germany

Stefan Brocke

This inventor holds 1 USPTO granted patent. Top assignee: Imtm Gmbh. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stefan Brocke. Retrieved from https://idiyas.com/inventor/stefan-brocke-792rz7ir

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Stefan Brocke

Introduction

Stefan Brocke is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of enzyme inhibitors, particularly in the context of autoimmune diseases and chronic inflammatory conditions. His innovative approach combines multiple enzyme inhibitors to enhance therapeutic efficacy.

Latest Patents

Stefan Brocke holds a patent titled "Combinations of enzyme inhibitor-containing preparations and the use thereof." This invention outlines a process that inhibits DNA synthesis and the proliferation of mononuclear cells and T cells through the simultaneous inhibition of various enzymes. The patent demonstrates that using multiple inhibitors together produces a more effective and lasting impact than using a single inhibitor alone. This groundbreaking work has implications for treating autoimmune diseases and managing rejection episodes following transplantation.

Career Highlights

Stefan Brocke is associated with Imtm GmbH, where he continues to develop innovative solutions in the field of biochemistry. His research focuses on the therapeutic applications of enzyme inhibitors, showcasing his commitment to advancing medical science.

Collaborations

Stefan collaborates with talented professionals such as Dirk Reinhold and Marco Arndt. Their combined expertise contributes to the success of their projects and enhances the potential impact of their innovations.

Conclusion

Stefan Brocke's work exemplifies the power of innovation in addressing complex medical challenges. His patent on enzyme inhibitors represents a significant advancement in therapeutic strategies for autoimmune and chronic diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…